Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value:
$2.48B
Total Bought:
$101.12M
Total Sold:
$452.34M
Net Transaction:
-$351.21M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
DLocal LimitedCL A(DLO)46,656,69536,814,136-9,842,559$606.30M$506.56M20.42%-$99.74M
Chime Financial, Inc.CL A(CHYM)21,259,68318,926,627-2,333,056$435.40M$504.21M20.33%+$68.81M
Liftoff MobileCL A25,315,64625,315,6460$608.08M$399.99M16.12%-$208.09M
XP Inc.CL A(XP)20,566,13317,958,953-2,607,180$334.41M$377.05M15.20%+$42.64M
Alkami Technology, Inc.(ALKT)19,379,03819,379,0380$351.15M$265.30M10.69%-$85.85M
Seaport Therapeutics6,101,5826,101,5820$132.53M$123.07M4.96%-$9.46M
Riskified Ltd.CL A(RSKD)5,324,99810,649,996+5,324,998$26.84M$84.24M3.40%+$57.40M
Nurix Therapeutics, Inc.(NRIX)3,032,1853,032,1850$73.56M$71.89M2.90%-$1.67M
Pharvaris
COM
6,550,7571,651,490-4,899,267$226.53M$52.39M2.11%-$174.14M
Parabilis Medicines1,538,4611,538,4610$42.11M$49.68M2.00%+$7.57M
Korsana01,366,242+1,366,242$0$43.72M1.76%+$43.72M
Grove CollaborativeCL A2,474,8592,474,8590$3.09M$2.62M0.11%-$470.2K
Revolution Medicines, Inc.(RVMD)357,7910-357,791$67.01M$0—-$67.01M
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q3 2026 | TickerTrail